ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome. Founded in 2020, ROME Therapeutics is backed by investors that include ARCH Venture Partners, GV, and Partners Innovation Fund and is headquartered in Cambridge.
FOUNDED:
2020
INDUSTRY:
Biotechnology, Pharmaceutical
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
